In committee
HALT Fentanyl Act
This legislation permanently classifies all chemical copies of fentanyl as Schedule I illegal drugs, exposing unauthorized makers and traffickers to strict federal bans and mandatory minimum prison sentences. At the same time, it speeds up the approval process for scientists and universities to legally research these substances for medical and public health purposes. Under these rules, qualified researchers face shorter government wait times, reduced paperwork across local lab facilities, and fewer licensing hurdles when creating small test samples.
People affected—not determinable from the text provided
Fiscal magnitude—not determinable from the text provided
Reach65provisional · pending reviewrigor: heuristic llm
What this bill touches.
Sentencing & corrections−60Drugs & enforcement−60
Who it helps · who it burdens.
Who it helps
- scientific and medical researchersGain expedited DEA review timelines, single-registration coverage for multiple local sites, exemptions from repeated site inspections, and permission to synthesize or modify small quantities of substances for research without a separate manufacturer license (Sec. 3(a)–(f)).
- laboratory technicians and research staffCan handle and conduct research with controlled substances under a registered colleague's credential without applying or paying for their own separate federal registration (Sec. 3(b)(1)).
Who it burdens
- individuals convicted of illicitly manufacturing or trafficking fentanyl-related substancesFace permanent Schedule I controlled substance penalties and federal mandatory minimum prison sentences for trafficking, importing, or exporting fentanyl-related chemical analogues (Sec. 2, Sec. 6(a)–(b)).
- supervising registered researchersMust assume legal liability for any controlled substance violations committed by unregistered staff members working under their registration during DEA suspension or revocation proceedings (Sec. 3(b)(1)).
- Drug Enforcement AdministrationMust act on certain research registration notices within 30 to 45 days, publicly publish any unique evaluation criteria for specific substances, and promulgate implementing regulations within six months (Sec. 3(a), Sec. 3(g), Sec. 5).
- Department of Justice Office of the Inspector GeneralMust conduct a study and submit a report to Congress within one year examining federally conducted or funded research involving fentanyl (Sec. 3(a)(2)(n)(7)).